Literature DB >> 31199558

Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.

Deborah O Himes1, Deborah K Gibbons1, Wendy C Birmingham2, Renea L Beckstrand1, Amanda Gammon3,4, Anita Y Kinney5,6, Margaret F Clayton7.   

Abstract

Genetic test results have important implications for close family members. Indeterminate negative results are the most common outcome of BRCA1/2 mutation testing. Little is known about family members' understanding of indeterminate negative BRCA1/2 test results. The purpose of this mixed-methods study was to investigate how daughters and sisters received and understood genetic test results as shared by their mothers or sisters. Participants included 81 women aged 40-74 with mothers or sisters previously diagnosed with breast cancer and who received indeterminate negative BRCA1/2 test results. Participants had never been diagnosed with breast cancer nor received their own genetic testing or counseling. This Institutional Review Board-approved study utilized semi-structured interviews and surveys. Descriptive coding with theme development was used during qualitative analysis. Participants reported low amounts of information shared with them. Most women described test results as negative and incorrectly interpreted the test to mean there was no genetic component to the pattern of cancer in their families. Only seven of 81 women accurately described test results consistent with the meaning of an indeterminate negative. Our findings demonstrate that indeterminate negative genetic test results are not well understood by family members. Lack of understanding may lead to an inability to effectively communicate results to primary care providers and missed opportunities for prevention, screening, and further genetic testing. Future research should evaluate acceptability and feasibility of providing family members letters they can share with their own primary care providers.
© 2019 National Society of Genetic Counselors.

Entities:  

Keywords:  BRCA1/2 genetic testing; family communication; genetic counseling; genetic risk communication; indeterminate negative test results; precision medicine

Mesh:

Year:  2019        PMID: 31199558      PMCID: PMC7340114          DOI: 10.1002/jgc4.1147

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  20 in total

1.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder.

Authors:  G K Suthers; J Armstrong; J McCormack; D Trott
Journal:  J Med Genet       Date:  2005-12-21       Impact factor: 6.318

2.  No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.

Authors:  Michel Dorval; Geneviève Gauthier; Elizabeth Maunsell; Michel J Dugas; Isabelle Rouleau; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Michel Gaudet; Peter J Bridge; Jacques Simard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

3.  Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas.

Authors:  M Trottier; J Lunn; R Butler; D Curling; T Turnquest; R Royer; M R Akbari; T Donenberg; J Hurley; S A Narod
Journal:  Clin Genet       Date:  2014-09-06       Impact factor: 4.438

4.  Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication.

Authors:  Jan Hodgson; Sylvia Metcalfe; Clara Gaff; Susan Donath; Martin B Delatycki; Ingrid Winship; Loane Skene; MaryAnne Aitken; Jane Halliday
Journal:  Eur J Hum Genet       Date:  2015-07-01       Impact factor: 4.246

5.  Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.

Authors:  Anita Y Kinney; Karin M Butler; Marc D Schwartz; Jeanne S Mandelblatt; Kenneth M Boucher; Lisa M Pappas; Amanda Gammon; Wendy Kohlmann; Sandra L Edwards; Antoinette M Stroup; Saundra S Buys; Kristina G Flores; Rebecca A Campo
Journal:  J Natl Cancer Inst       Date:  2014-11-05       Impact factor: 13.506

6.  The Long and Short of Genetic Counseling Summary Letters: A Case-control Study.

Authors:  J Roggenbuck; R Temme; D Pond; J Baker; K Jarvis; M Liu; S Dugan; N J Mendelsohn
Journal:  J Genet Couns       Date:  2014-12-14       Impact factor: 2.537

7.  Factors Influencing Clinical Follow-Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing.

Authors:  Sarah E Chadwell; Hua He; Sara Knapke; Jaime Lewis; Rebecca Sisson; Jennifer Hopper
Journal:  J Genet Couns       Date:  2018-03-17       Impact factor: 2.537

8.  Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.

Authors:  C Cypowyj; F Eisinger; L Huiart; H Sobol; M Morin; C Julian-Reynier
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894

9.  A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.

Authors:  Joël Vos; Fred Menko; Anna M Jansen; Christi J van Asperen; Anne M Stiggelbout; Aad Tibben
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

10.  Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.

Authors:  Deborah O Himes; Margaret F Clayton; Gary W Donaldson; Lee Ellington; Saundra S Buys; Anita Y Kinney
Journal:  J Genet Couns       Date:  2015-08-07       Impact factor: 2.537

View more
  1 in total

1.  Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.

Authors:  Anne Brédart; Jean-Luc Kop; Julia Dick; Alejandra Cano; Antoine De Pauw; Amélie Anota; Joan Brunet; Peter Devilee; Dominique Stoppa-Lyonnet; Rita Schmutzler; Sylvie Dolbeault
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.